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Campus, Coldharbour Lane, Bristol, BS16 1QY, UK 
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Abstract: 
Analysis of VOCs from saliva, to aid disease diagnoses, has received little attention. This work 
aims to address the paucity of information on saliva volatiles and includes a database of newly 
identified compounds whilst incorporating a review of the literature.  The volatile constituents in 
the headspace of whole saliva obtained from 10 healthy individuals were examined in a 
longitudinal study over a period of 10 days using Headspace-Trap Gas Chromatography-Mass 
Spectrometry (HS-Trap-GC-MS). A total of 317 compounds (268 identified) were found and 
compared across subjects and between samples with 34 VOCs being present in all 100 samples. 
The average number of compounds per subject ranged from 121 to 150 over a 10 day period and 
was fairly consistent for a particular individual (s.d. ranged from 3-15). However, the number of 
compounds present in an individual on all 10 days was substantially lower ranging between 65 
and 109, showing that there is significant daily variation in salivary composition. A core group of 
ubiquitous VOCs were found with the remaining VOCs showing significant intra and inter 
individual variability. Saliva VOCs have been found to be readily analysed using the HS-trap 
technique and studies on the VOCs from healthy individuals should be of utility for comparison 
with VOCs analysed from samples from diseased groups.   
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1. Introduction 
The first recorded use of the smell of saliva was undertaken by the ancient Chinese for 
tuberculosis diagnoses, spitting onto a hot stone was purported to produce a diagnostic tarry 
smell. Saliva is a readily available, exocrine fluid originating in the oral cavity. A typical human 
can produce 500-1500 ml day
-1
 at a rate of about 0.5 ml minute 
-1 
(Chiappin et al 2007, Pfaffe et 
al 2011).  
Whole saliva includes a number of VOCs which could be derived from serum, blood, gingival 
exudates, skin lipids, microorganisms, commercial products, medicines, environmental pollution, 
and food debris (Kaufman and Lamster 2002a, Kaufman and Lamster 2002b, Kostelc et al 1981, 
Martin et al 2012), the oropharynx, nasal cavity,  upper airway and from gastrointestinal reflux 
(Lima et al 2010, Pfaffe et al 2011, Soini et al 2010, Kusano et al 2011, Kaufman and Lamster 
2002a, Alagendran et al 2010).  
Over 300 bacterial species were reported to be present in the oral cavity (Soini et al 2010). 
Microbial activity in the mouth produce putrefactive compounds such as aliphatic amines, 
branched chain fatty acids, indole, phenol and volatile sulphur containing compounds (VSC) 
(Imamura 1982, Yang 2002, Calil et al 2008, Calil and Marcondes 2006, Kostelc et al 1981, 
Tonzetich & Carpenter 1971, Kakoei et al 2012). Stress and anxiety may induce changes in the 
oral microbiota which increases oral volatiles, especially the VSCs (Calil and Marcondes 2006).   
Passive diffusion is the most common exchange methodology between blood and saliva 
(Kaufman and Lamster 2002b, Pfaffe et al 2011, Kidwell et al 1998, Chiappin et al 2007), 
although other methods such as ultrafiltration and active diffusion are also present. Saliva 
therefore reflects the biochemical and metabolic information in blood which makes saliva 
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analysis a potential tool for the study of physiological and pathological conditions. Nagler et al 
(2002) found a correlation between compounds in blood and saliva. Saliva has a lower 
concentration of constituents than blood due to the diurnal/circadian variations of certain 
compounds (Kumar et al 2009, Lima et al 2010). Lipophilic and neutral molecules diffused more 
easily into saliva than lipophobic, hydrophilic and ionised molecules (Lochner et al 1986). 
VOCs in breath dissolve in saliva influencing its composition (Soini et al 2010). Humans are 
exposed to organic chemicals via inhalation, consumption, ingestion of contaminated food and 
transdermal absorption (Soini et al 2010, Sanchez et al 2012). Environmental exposure to 
chemicals that originate from commercial products such as; toothpastes, mouth washes, soaps, 
shampoos, cosmetics, medicines, plastics, paints, and pesticide formulations have been reported 
in the literature (Kumar et al 2009, Soini et al 2010) and lead to some of these chemicals being 
identified in saliva (Kostelc et al 1981).  Also the exposure to air pollutants especially 
compounds derived from engine exhaust gas such as gasoline and diesel (Sheng et al 2006and 
Scultz et al 1999).  
Saliva analysis offers an alternative solution to invasive, time-consuming, complicated, and 
expensive diagnostic methods using specimens such as blood, serum, urine and faeces. Saliva 
sampling requires minimal training and cost and no specialist equipment is required. The 
collection process is free of stress, discomfort and is more acceptable to patient than giving 
blood, faeces or urine samples. Saliva specimens can be collected without external stimulation 
by spitting in a vial or by passive drooling with no oral movements. (Martin et al 2012, Chiappin 
et al 2007).  
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Hydration, olfactory stimulation, exposure to light, body positioning, seasonal and diurnal 
factors can affect the quantity and composition of un-stimulated saliva (Martin et al 2012, 
Chippin et al 2007). Sample collection, storage, preparation and the degree of saliva stimulation 
can influence the observed composition (Gröschl and Rauh 2006; Schipper et al 2007, Soini et al 
2010, Chiappin et al 2007). Volatiles can evaporate or become adsorbed/absorbed onto the 
surfaces of the materials during collection and storage, many VOCs degrade because of 
microbial activity after collection (Martin et al 2012).  Higher bacterial loadings occur from 
spitting hence the passive drool approach is commonly adopted to minimize such effects (Martin 
et al 2010, Chippin et al 2007). Inhibitors and/or denaturing agents such as sodium azide can be 
used to stop bacterial growth, degradation to the molecules and any enzyme activity (Schipper et 
al 2007, Chiappin et al 2007, Martin et al 2012).  
Several methodologies and techniques have been employed to study the volatile organic 
compounds in saliva. Larsson (1965) directly injected saliva headspace and breath samples into a 
GC/FID. They reported the presence of four compounds, tentatively assigned as acetone, 
acetaldehyde, ethanol and methanol and assessed the influence of food, alcohol, oral hygiene and 
smoking on their concentrations. Locher et al (1986) investigated saliva as a vehicle for the non-
invasive detection of diabetes and liver disease, producing individual metabolic volatile profiles 
using solvent extraction/derivitisation combined with GC-MS. They compared saliva volatiles 
collected 12 hours apart. They identified 26 compounds and found significant differences in the 
metabolic profiles from diabetic and non diabetic individuals. Their study of a liver disorder 
group failed to produce any definitive differences. Alagendran et al (2010) used solvent 
extraction/derivatisation with GC-MS to identify salivary volatiles during the menstrual cycle to 
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assess ovulation and reproductive phases in women. They identified that 2-nonenal, acetic acid, 
acetaldehyde and dodecanol are ovulatory specific whereas butanoic acid, 2-propenyl ester, 
skatole and 3-hexanol were present in follicular and luteal phases.  
Stir-bar extraction followed by GC-MS was used by Penn and Soini (Penn et al, 2007 and Soini, 
et al 2010) to investigate the volatile composition of sweat, skin and saliva from a large group of 
197 individuals. They identified 88 volatile compounds in saliva. Half of the compounds were 
common to skin, sweat and saliva. Individual variability among the salivary VOC profiles was 
attributed to variation in diet, environment and genetics.  
Dynamic headspace extraction using a Tenax trap combined with GC-MS (Kostelc et al 1981) 
was used to study headspace exogenous volatiles in stimulated saliva collected from 17 subjects 
(3 females and 14 males). They found 29 compounds in these subjects, attributing the majority to 
sources such as urban air, drinking water, diet and cosmetic preparations.  
Several papers investigated sampling, extraction and enrichment techniques for use with saliva 
samples. Solid phase microextraction (Kumar et al 2009, Kusano et al 2011, Wang and Ming-
Yen 2009, Buszewski et al 2007), headspace single-drop microextraction (SDME) (Jermak et al 
2006) and a polydimethylsiloxane coupon (placed in the oral cavity), (Martin et al 2012) have 
been used in the study of saliva.  
A small study (Sanchez et al 2011) coupled a headspace sampler (HS) directly with GC-MS for 
determination of biomarkers in 28 unstimulated saliva samples: 24 from healthy volunteers, and 
4 from patients with different types of disease (including lung, colon and stomach cancer). 
Methyl tert-butyl ether and styrene were considered as biomarkers of exposure to environmental 
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pollutants and dimethyl disulfide, limonene and 2-ethyl-1-hexanol were considered to be 
biomarkers for diseases.  
In the present study, the headspace-trap (HS-trap) technique in conjunction with GC–MS has 
been applied for the first time for determination of VOCs in human saliva. The HS-Trap is an 
enhanced static HS system that traps, focuses and pre-concentrates volatiles prior to gas 
chromatography without sample preparation. It has sensitivity and detection limits similar to the 
conventional purge and trap technique (Barani et al 2006). This method has been applied for 
trace analysis of volatile organic compounds in environmental samples, pharmaceuticals, soil, 
food products, and water (Barani et al 2006, Schulz et al 2007, Røen et al 2010, Meng et al 
2009).  
This pilot study aimed firstly to investigate the salivary headspace volatiles of normal healthy 
individuals to establish a “normal volatile profile”, and provide a basis for the future use of 
salivary VOCs as a diagnostic medium for diseases. Secondly, this work aimed to assess the 
daily variation of the VOCs in healthy individuals over a 10 day period. 
 
2. Materials and Methods 
2.1. Participants: 
Ethical approval for the study was granted by the university research ethics committee. Informed 
and written consent was obtained from all participants. Ten participants in good systemic health 
aged from 22-41 and of mixed gender (7 males and 3 females) took part in the study. They kept a 
record of their dietary intake over the 10 day sampling period. Participants did not have any 
dietary restrictions imposed. Subjects were requested to fast overnight (The cut off time for 
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overnight fasting was 8pm) and they were requested to only drink water prior to sampling. 
Alcohol consumption was not permitted during the period of the study. In addition, participants 
had to be free of fever and/or cold. Participants taking medication, smokers and ex-smokers were 
excluded from the study. The participants were asked not to undertake strenuous physical 
activity prior to sampling. This was only limited prior to the sample collection. 
2.2. Sample Collection  
The sample collection technique, handling, and storage were carefully designed to maximize 
measurement and validity of salivary volatiles and minimize the influence of extraneous factors 
on the salivary profile.  A non-stimulated collection approach similar to (Martin et al 2012 & 
Mohamed et al 2012) was chosen in order to minimise the introduction of any contaminants to 
the samples. The sampling protocol was standardised to ensure consistency of results between 
samples and subjects. All saliva samples were collected between 9 – 11 am. They were allowed 
to brush their teeth as usual in the morning but were requested not to use mouthwash.  Prior to 
sampling, participants were asked to rinse their mouths at least 20 times using 750 ml of still 
bottled water (Love One, Global Ethics Ltd. bottled at source at Powys/Wales by Radnor Hills 
Mineral Water Company Ltd. Quoted mineral composition: calcium 44mg/l, potassium 2mg/l, 
sodium 37 mg/l, sulphate 10.9 mg/l, magnesium 6.8 mg/l, nitrate 15 mg/l, chloride 13 mg/l, 
fluoride 0.09 mg/l and the total dissolved solids were 214). The volatile composition of the water 
was also tested to eliminate any influence on the volatiles in the mouth prior to sampling.  
After the water rinse they waited 10 minutes before commencing collection to avoid sample 
dilution. The participants were instructed to sit in an upright position, to tilt their head forward to 
allow saliva to flow from their mouth into glass headspace vials (Perkin Elmer 22 ml vials with 
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aluminum crimped caps and PTFE lined silicone septa). They were asked to weigh 2 gm of their 
own saliva using an analytical balance. The samples of saliva per person which had accumulated 
in the vial weighed 2gm ± 0.1. The vials were then immediately crimped and without any 
processing stored in a freezer at -20 °C until analysis.  Saliva specimens were analysed within 24 
h of collection. All samples were collected in the same room at the same time of day. Samples of 
indoor lab air were conducted during the study to determine the lab air volatiles to eliminate any 
interference from the surrounding environment. For method validation 4g aliquots of saliva were 
portioned into two vials one was run immediately fresh and the other was frozen for 24 hours, 
subsequently defrosted at 20
o
C for 20 minutes and then run using the same method as the fresh 
samples. Analysis showed that there was minimal difference between the two chromatograms. 
The same compounds were identified in both samples and the majority of the peaks present were 
at a similar level. The differences between fresh and frozen samples were in line with differences 
in the chromatograms observed when 4g samples of saliva were portioned into two vials and 
both run fresh or frozen. 
   
2.3. Volatile sampling using HS-Trap GC-MS  
A relatively new type of headspace sampler, the Turbomatrix HS40 Trap (Perkin Elmer, 
Wellesley, MA), which combines headspace sampling with a trap was utilised in this study. This 
was interfaced to a Clarus 600 GCMS system (Perkin Elmer). The HS40 Trap instrument has a 
good LOD similar to purge and trap methods, good repeatability similar to static headspace 
techniques and enables water to be removed prior to the chromatographic stage. A good 
overview of the method is described in Barani et al. (Barani et al 2006). The HS 40 Trap works 
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with the pulsed-pressure approach, combining a slight modification of the balanced pressure 
principle with the use of an on-board cold and packed trap to extend its detection limits. The 
following steps are undertaken during the analysis:  
Thermal equilibriation of the sample  
The sample vials were heated in the HS trap to 80 °C for 20 minutes to ensure that the vapour 
reached chemical equilibrium.  
Pressurization step 
The needle pierces the septum, and carrier gas (helium at 31psi) is used to pressurize the vial to a 
user defined value. Simultaneously, a valve isolates the GC column, minimising column pressure 
change. The column isolation flow is manually set by the operator 10mL/min higher than the 
column flow. 
Trap load stage 
The headspace of the vial is sent to the cold packed trap, allowing a flow of headspace through 
the trap. There is the option to repeat this trap load step upto four times for each vial. 
Trap dry purge 
The cold packed trap is purged with helium to eliminate water.  
Trap desorb and trap hold 
The trap temperature is increased to the set level at a rate of 400oC/min to release the trapped 
analytes. It is the kept at that value for a specified time to clean the trap. Once the trap is heated 
the isolation of the column from the carrier gas flow is ceased and the GC run starts. THe 
volatile are introduced into the GC via a fused silica transfer line maintained at 120°C.  
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Extensive method development was undertaken in order to determine the correct instrument 
parameters to optimize the analysis of saliva and other biological fluids. Table 1. gives a 
summary of the instrumentation and the various instrument parameters used during the salivary 
analysis.  
 
Table 1. Experimental conditions and instrument parameters. 
Parameter Setting 
 
Headspace Trap Conditions 
Sample Introduction PerkinElmer TurboMatrix HS 40 Trap 
Thermostatting  80 °C for 20 min 
Needle 100 °C 
Transfer Line 120 °C, 2 m × 320 µm  
Carrier gas Helium at 31 psi 
Dry Purge Helium, duration 15 min 
Trap Air toxic trap (supplied with HS40-Trap instrument), Trap low temp: 40 °C, Trap high 
temp:320 °C, Trap hold: 10 min 
Extraction cycle 1 cycle at 45 psi 
 
Chromatography Conditions 
GC PerkinElmer Clarus 600 GC 
Column Zebron Capillary ZB-624, Dimensions: 60 m length, 0.25 mm I.D., 1.4 µm film thickness 
Oven 35 °C for 10mins, then 8 °Cmin
-1 
to 200 °C no hold, 15 °Cmin-1 to 220°C for 12 min 
Injector Split Splitless (PSS), Split control/OFF, Flow mode 
 
Mass Spectrometry Conditions 
MS PerkinElmer Clarus 600 MS 
Mass range 33-300 Dalton 
Scan Time 0.25 s 
Interscan Delay 0.08 s 
Inlet Line  220 °C 
Source Temperature 180 °C 
Multiplier 400 
 
Software 
Software TurboMass 5.4.2 
Search Library and 
Database 
Compounds were identified by comparing their mass spectra with those contained in the 
NIST 2008 version, peak was searched manually (baseline subtraction and averaging over 
the peak).Forward and reverse match quality of at least 800/1000 was used as a lower 
match threshold, otherwise the compound was labeled unknown. Identity of x compounds 
were confirmed using standards. 
 
3. Results  
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The volatile constituents in the headspace of whole saliva obtained from 10 individuals were 
examined in a longitudinal study over a period of 10 days.  A total of 268 identified compounds 
(plus 49 unassigned peaks) were found and compared across subjects and between samples. (See 
Table 2 for more details). 34 Compounds were found to be ubiquitous to all 100 samples. 
The classes of VOCs found in saliva and their percentage compositions were; 26 aldehydes (8%, 
3 ubiquitous), 22 alcohols (7%, 6 ubiquitous), 117 hydrocarbons (38%, 13 ubiquitous), 12 esters 
(4 %), 3 ethers (1 %), 40 ketones (13%, 5 ubiquitous), 30 aromatic compounds (9%, 4 
ubiquitous), 9 Volatile Sulfur Compounds (VSCs) (3%), 5 Nitrogen containing compounds (2%, 
2 ubiquitous), 1 acid (0.3 %), 3 others (1 %), and 49 unknowns (15%, 1 ubiquitous).   
Hydrocarbons were the largest group with 117 compounds which included 46 terpenes, 12 
cycloalkenes, 17 branched alkenes, 18 straight chain alkenes, 10 cyclic alkanes, 6 branched chain 
alkanes, 8 straight chain alkanes. 
The mean total number of VOCs identified, per subject, was 192 (SD 13, range 171 to 211) see 
Table 3 for details. The mean number of VOCs identified per person per day as illustrated in 
Table 3, was 137 (SD 3.6) (range 121 to 150). The number of compounds identified for each 
individual per day was quite consistent illustrated by the relatively small standard deviation for 
most subjects (range 3-15). However, if you consider the compounds that are consistently 
present in each individual over the 10 day period then the mean is much lower 87 (SD16) (range 
65-109). This shows that despite the relatively consistent numbers of compounds per individual 
per day, the types of volatiles identified are subject to daily variation.  
The inter subject and the overall variability in the abundance (peak area) of ubiquitous 
compounds is shown in Table (4), with selected compounds also included in Figure 1. There is 
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not an overall trend in the abundances of the 34 ubiquitous compounds although analysis of 
figure 1 and table 4 show that changes in the abundance of certain compounds seem to be closely 
linked for certain individuals. Some of these are discussed specifically below. There are 3 
predominant behaviours observed (see Table 4). Firstly a pattern of low to moderate variability 
where all subjects are broadly overlapped. Compounds in this group have relatively low 
individual and overall variation in measured peak areas. Secondly, a similar pattern but where 1 
or more individuals exhibit a peak on a certain day (or raised response over a number of days 
returning gradually to the baseline). Compounds in this group have high variability for certain 
individuals contributing to a high overall variability. Thirdly where one or more subjects have a 
high baseline level of a certain compound over the 10 day period, but where the variability is 
comparable to the other subjects. This group is characterized by relatively low individual 
variability but a high overall variability. 
2-methyl-1-butanol (figure 1a) shows limited variation between individuals and limited overall 
variation showing that the salivary profiles of the subjects over a 10 day period are broadly 
overlapped.  
Inter subject variability of the peak area for styrene (Figure 1b), o-xylene and 2-heptanone were 
low, except for subject 2 on day 6 where there was a large peak. In the case of isopropyl alcohol 
(Figure 1c) and acetone (Figure 1d) most subjects exhibited a low variability; however subject 5 
exhibited a peak on day 2, which returned to the “baseline” value by day 6.  For the case of 
ethanol a number of the subjects exhibit peaks on different days (see Figure 1e), with subject 6 
giving a large peak on day 6.   
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It can be seen that subject 4 has higher baseline levels of limonene (Figure 1f) and 1-propanol 
(Figure 1g). In addition the following compounds were observed to follow this same general 
trend for subject 4, p-cymene, dehydro-p-cymene, alpha-pinene, 3-(2-propenyl)-cyclohexene, 1-
butanol, 1-propanol and p-xylene. However table 4 shows that this subject doesn’t have 
significantly higher variability when compared to the other subjects. In fact in the case of p-
cymene, dehydro-p-cymene and limonene, subject 9 exhibits a more significant individual 
variation compared to the other subjects.  
Octane (Figure 1h) was unusual as 7 of the 10 individuals exhibit a relatively high individual 
variation.  
 4. Discussion 
Table 2 lists all the VOCs found in this study with references to previous studies where the same 
volatiles have been identified previously.  
A total of 147 salivary VOCs have been reported in the literature, of which 35 VOCs were 
common with this work. Classes of compounds in the literature and their percentage composition 
were; 12 aldehydes (8 %), 15 alcohols (10 %), 30 hydrocarbons (20 %), 20 esters (14 %), 4 
ethers (3 %), 19 ketone and lactones (13 %), 10 aromatics compounds (7 %), 3 VSCs (2 %), 27 
acids (18 %) and 7 Nitrogen containing compounds including an amine and 5 amides (5%) . 
Only 9 of the 34 ubiquitous compounds from this study were identified in the combined 
literature studies. These were ethyl alcohol, isopropyl alcohol, indole, phenol, styrene, 
dodecanal, acetone, 2-heptanone and limonene. 
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Methodologies examining VOCs in the literature showed distinctly different selectivity for 
specific compounds and different volatile compositions, when compared with that of the HS-
Trap-GC-MS described here. There was the use of different sample preparation techniques such 
as solvents extraction, derivatisation (Locher et al 1986, Alagendran et al 2010). The 
methodologies reported in the literature also utilised volatile extraction steps using sorbent traps 
such as tenax (Kostelc et al 1981) and stir-bar sorptive extraction (Penn et al 2007 and Soini et 
al 2010). The methods also involved the use of different analytical equipment and different 
analytical methods, such as column type, column conditions, detector type etc. All this might 
explain the different proportions of VOCs identified. As mentioned some of the methods such as 
solvent extraction were able to identify semi-volatile and even relatively non-volatile compounds 
which this method would not have identified. The HS-Trap-GC-MS method involved no sample 
preparation steps and was found to detect a wide array of volatile compounds especially 
hydrocarbons. This method was not as selective to polar compounds such as carboxylic acids, 
amines and amides. 
The earliest report on the analysis of saliva was the injection of headspace vapour into a GC/FID 
(Larsson 1965) using a glass capillary column. They only detected 4 compounds a ketone, 2 
alcohols and an aldehyde. Using a dynamic headspace extraction method utilising a Tenax trap 
coupled with GC-MS (Kostelc et al 1981) identified 29 VOCs including 2 ketones, 5 
hydrocarbons/terpenes, 6 alcohols, an aldehyde, 3 esters and 3 VSCs, 8 aromatic compounds and 
an amine. Using solvent extraction/derivitization combined with GC-MS (Locher et al 1986) 
identified 26 compounds including 15 straight and branched chain, saturated and unsaturated 
acids, 7 long chain alkane hydrocarbons, 3 fatty alcohols and 1 aromatic compound. Alagendran 
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et al (2010) used solvent extraction/derivatisation with GC-MS and identified 15 VOCs, 4 
carboxylic acids, 2 branched alkanes, 2 long chain alcohols, 2 aldehydes, 3 aromatic compounds 
an ester and an amine. Stir-bar extraction followed by GC-MS identified. 88 VOCs (Penn et al 
2007 and Soini et al 2010), including 15 ketones, 15 carboxylic acids, 19 hydrocarbons including 
terpenes, 3 alcohol, 10 aldehydes, 4 ethers, 17 esters, 2 aromatic and 3 amides. This method 
exhibited higher selectivity to acids and esters. Sanchez et al, (2011) report a HS GC-MS method 
for saliva analysis although they did not analyse whole saliva samples. It is expected that fewer 
VOCs would be detected using this technique due to the absence of the trapping, focusing and 
concentration steps.  
 117 hydrocarbons identified by the HS-Trap-GC-MS, represent 37 % of the total of VOCs 
detected. 13 of which were ubiquitous (Octane, Limonene, p-Cymene, Dehydro-p-cymene, 
1S,2S,5R-1,4,4-Trimethyltricyclo[6.3.1.0(2,5)]dodec-8(9)-ene, Hexane, E or Z-1,3-Octadiene 
Stereoisomers1, E or Z-1,3-Octadiene Stereoisomers2, 3-(2-propenyl)-Cyclohexene, 1R-α-
Pinene, trans-Carane, Calamenene isomer 1, Z -2-Octene). These compounds particularly 
terpenes are mostly attributed to food from plant origin such as fruit, vegetables and herbs 
(Belitz et al 2009). They are also found in fragrances, perfumes and personal care products 
(Breitmaier 2006). However, many of these compounds are also common air pollutants derived 
from diesel and petrol fumes, such as the long chain n-alkane derivatives hexane, octane, decane, 
undecane, and hexadecane. (Sheng et al 2006 and Schulz et al 1999). 
Ketones and lactones represent 13 % of the VOCs in saliva, 5 of these were ubiquitous (2,3-
Butanedione, 2-Heptanone, Acetone, 2,4-dimethyl-3-Pentanone, 2,3-Pentanedione). Diet is a 
possible source for some of these ketones, such as 2-heptanone which was found in cheese (Jelen 
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et al 2002). Ketones such as acetone and 2-butanone can be formed endogenously from fatty 
acids and carbohydrates metabolisms (Garner et al 2007). Others could arise from bacterial 
metabolism such as 2,3-butanedione from lipids and 2,3-pentanedione from carbohydrates (Ott et 
al 2000).  
Aromatics compounds represent 9 % of the VOCs in saliva. 4 of which were ubiquitous (Phenol, 
o-Xylene, Styrene, p-Xylene). The sources of some of these compounds were mainly dietary 
such as estragole, anethole (Mudge et al 2008). Phenol and Indole could arise from the 
metabolism of aromatic amino acids tyrosine, phenylalanine and tryptophan by the action of 
bacteria and fungi (Calil et al 2006, Kriek et al 2007, Garner et al 2007, Smith and Macfarlane 
1997). Benzaldehyde was found in foods such as almond and cherry (Pićurić-Jovanović and 
Milovanović 1993, Yang Sun et al 2010) but is also a common air pollutant derived from vehicle 
emissions (Sheng et al 2006 and Schulz et al 1999). Many of the other compounds are also 
common outdoor air pollutants derived for example from diesel or petrol fumes. These emissions 
contain higher abundances of the lower-boiling aromatic hydrocarbons, such as benzene, 
toluene, ethylbenzene, xylenes, styrene, 1,2,4-trimethylmethylbenzene.(Sheng et al 2006 , 
Schulz et al  1999, Kusano et al 2011, Kostelc et al 1981).  
 
Aldehydes represent 8 % of the VOCs detected of which 3 were ubiquitous. Some of these 
aldehydes can be attributed to dietary sources, such as dodecanal which could be naturally 
derived from plant or animal oils and fats (Mudge et al 2008) and were found in dairy, fruit and 
fish and in some bacterial cells (Varlet et al 2007).  Volatiles such as hexanal and nonanal were 
considered a general marker for oxidative stress. (Fuchs et al 2010). Both could be endogenously 
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produced from membrane lipid oxidation (Frampton et al 1999) and both were reported to be in 
food (Delacy Costello et al 2001). 
Alcohols represent 7 % of the total VOCs identified in this study of saliva, with 6 ubiquitous 
compounds in each group (Ethyl alcohol, Isopropyl Alcohol, 1-Propanol, 2-methyl-1-Propanol, 
1-Butanol, 2-butyl- 1-Octanol). The sources of some these compounds were mainly dietary such 
as 2-butyl-1-octanol which is found in plant and animal oils (Mudge et al 2008). Ethanol can be 
found in alcoholic beverages, food, personal care products, perfumes and be derived from the 
metabolism of various microorganism’s (McKarns et al 1997, Garner et al 2007). 1-propanol and 
1-butanol were considered to arise from the biosynthesis of the amino acid isoleucine (Lamsen et 
al 2012).  
Esters represent 4% of the total VOCs identified. These compounds are naturally occurring in 
food and used in flavor, fragrances and essential oils (Belitz et al 2009). 
Volatile sulfur compounds represent 3% of the total compounds identified although none were 
found to be ubiquitous. Members of alliceae family, such as garlic and onion will introduce some 
sulphur containing compounds such as allyl mercaptan, allyl methyl sulfide, dimethyldisulfide, 
1- 1-(E)-/ (Z),(methylthio)-propene and 1-(methylthio)-propane (Kostelc et al 1981, Belitz et al 
2009, Lawson and Wang 2005) all were detected in this study. However, many of these 
compounds such as dimethyl disulfide have been identified in association with common oral 
anaerobic bacteria (Khalid et al 2013). The brassicaceae family which includes broccoli and 
cabbage will introduce some other compounds such as allylisothiocyanate and 
isothiocyanatocyclopropane (Olivier et al 1999, Egami et al 2011), which were also present in 
this investigation. Therefore the 9 VSCs found in this study possibly have a dietary origin.  
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Nitrogen containing compounds NCC represent 2% of VOCs identified in saliva (2 are 
ubiquitous, pyrrole and indole). Pyrrole and indole may arise from microbial action in the saliva 
(Imamura T 1982). 2-methyl pyridine and 3-methyl pyridine can be found in food (Newkome 
1984) and both are environmental contaminants (ref) with sources such as pharmaceuticals and 
agricultural industries. (ref).  
 Physical exercise such as cycling and walking might possibly alter the level of some volatiles 
such as acetone and indole levels (Yami et al 2009, Cooke et al 2003). Subject 8 especially on 
days 1 and 3 had done more physical exercise when compared to the other volunteers prior to 
sampling and was observed to have higher levels of acetone on those days. We found that for 
most subjects the levels of acetone and isopropyl alcohol followed similar trends. Acetone is 
formed via the decarboxylation of acetoacetate and the dehydrogenation of isopropylalcohol 
(Kalapos 2003). 
We have reported the application of a new technique (HS-Trap GC-MS) for the analysis of 
biological samples, specifically saliva. Our study has identified higher total numbers of VOCs 
than previously reported. Many of these volatiles had not been previously identified in saliva. 
The method is automated and traps headspace volatiles directly onto a cold trap thus removing 
certain selectivity issues that arise with other methods such as SPME, ATD etc. In addition this 
study was able to assess the change in volatile profile over a 10 day period for a number of 
volunteers. An in depth analysis of 34 ubiquitous compounds and the variation in their relative 
abundance was also undertaken. This work helps in establishing a baseline profile for salivary 
volatiles in healthy adults, although there is scope for more extensive studies to increase the 
database. It is important to have information on the composition and inter and intra subject 
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variability for key volatiles if studies to investigate the use of saliva for disease diagnosis are to 
be undertaken.   
 
4. Conclusion  
To our knowledge this longitudinal investigation is the most comprehensive study in the analysis 
of VOCs in saliva with 317 (268 identified) compounds reported to be found in the headspace 
The average number of compounds per subject over a 10 day period was found to be relatively 
consistent although the actual composition of these volatiles was subject to a degree of daily 
variation, with approximately 60-70% of volatiles consistently present in all 10 samples of a 
given individual. 
The HS-Trap-GCMS method used in this study has shown great utility for use in the detection of 
VOCs directly from the headspace of biological samples. This technique has great potential to be 
used for the detection of VOCs associated with disease.  . This is a relatively small pilot study 
addressed only at a small number of healthy individuals. In the future this study could be 
extended to include a larger number of individuals and measure them for a longer period of time 
or an extended number of time points during the day.  
The volatile profiles of salivary headspace from healthy volunteers were established and should 
provide a basis for the future use of salivary VOCs as a diagnostic medium for disease  
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Table (2): A longitudinal study of volatile organic compounds detected in saliva of healthy individuals over 10 days and a comparison with literature data (see references column) 
(In the RT confirmed column, if the compound has been identified by running a pure standard then 1 is inserted otherwise a 0 is inserted. 
 Compound 
Name 
RT 
confirmed 
Subject 
1 
Subject 
2 
Subject 
3 
Subject 
4 
Subject 
5 
Subject 
6 
Subject 
7 
Subject 
8 
Subject 
9 
Subject 
10 
Presence 
% 
References 
1 Ethyl alcohol 1 10 10 10 10 10 10 10 10 10 10 100 F,G 
2 Isopropyl alcohol 1 10 10 10 10 10 10 10 10 10 10 100 A 
3 1-Propanol 1 10 10 10 10 10 10 10 10 10 10 100  
4 2-methyl-1-
propanol,  
1 10 10 10 10 10 10 10 10 10 10 100  
5 1-Butanol 1 10 10 10 10 10 10 10 10 10 10 100  
6 Hexanal  1 10 10 10 10 10 10 10 10 10 10 100  
7 Nonanal  1 10 10 10 10 10 10 10 10 10 10 100  
8 2,3-Butanedione 1 10 10 10 10 10 10 10 10 10 10 100  
9 2-Heptanone  1 10 10 10 10 10 10 10 10 10 10 100 A 
10 Octane 1 10 10 10 10 10 10 10 10 10 10 100  
11 Limonene 1 10 10 10 10 10 10 10 10 10 10 100 F 
12 P-cymene 1 10 10 10 10 10 10 10 10 10 10 100  
13 Dehydro-p-
cymene 
1 10 10 10 10 10 10 10 10 10 10 100  
14 1S,2S,5R-1,4,4-
Trimethyltricyclo
[6.3.1.0(2,5)]dode
c-8(9)-ene 
1 10 10 10 10 10 10 10 10 10 10 100  
15 Pyrrole 1 10 10 10 10 10 10 10 10 10 10 100  
16 Phenol 1 10 10 10 10 10 10 10 10 10 10 100 C,E,F 
17 o-Xylene 1 10 10 10 10 10 10 10 10 10 10 100  
18 Styrene  1 10 10 10 10 10 10 10 10 10 10 100 F 
19 Dodecanal 1 10 10 10 10 10 10 10 10 10 10 100 B 
20 Acetone 1 10 10 10 10 10 10 10 10 10 10 100 A,F,G 
21 2,4-Dimethyl-3-
pentanone 
1 10 10 10 10 10 10 10 10 10 10 100  
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22 Hexane 1 10 10 10 10 10 10 10 10 10 10 100  
23 E or Z-1,3-
Octadiene 
Stereoisomers1 
1 10 10 10 10 10 10 10 10 10 10 100  
24 E or Z-1,3-
Octadiene 
Stereoisomers2  
1 10 10 10 10 10 10 10 10 10 10 100  
25 3-(2-propenyl)-
Cyclohexene 
0 10 10 10 10 10 10 10 10 10 10 100  
26 1R-α-Pinene 1 10 10 10 10 10 10 10 10 10 10 100  
27 trans-Carane 1 10 10 10 10 10 10 10 10 10 10 100  
28 unknown_37  
(Retention time 
37.75mins) 
 10 10 10 10 10 10 10 10 10 10 100  
29 Indole  1 10 10 10 10 10 10 10 10 10 10 100 F 
30  2-Butyl-1-
octanol 
0 10 10 10 10 10 10 10 10 10 10 100  
31 Calamenene 
isomer 1  
1 10 10 10 10 10 10 10 10 10 10 100  
32 2,3-Pentanedione 0 10 10 10 10 10 10 10 10 10 10 100  
33 Z -2-Octene  1 10 10 10 10 10 10 10 10 10 10 100  
34 p-Xylene 1 10 10 10 10 10 10 10 10 10 10 100  
35 (Z)-3-Dodecene 0 10 10 9 10 10 10 10 10 10 10 99  
36 Acetaldehyde 1 10 10 10 10 10 10 8 10 10 10 98 C, G 
37 (E)-3-Dodecene 0 9 10 10 10 10 10 9 10 10 10 98  
38 Methyl isobutyl 
ketone  
1 10 10 10 10 10 10 10 8 10 10 98  
39 2-Undecanone 1 8 10 10 10 10 10 10 10 10 10 98 B 
40 Benzaldehyde 1 8 10 10 9 10 10 10 10 10 10 97 F 
41 2-Nonanone 1 9 10 10 10 10 9 9 10 10 10 97  
42 (-)-Z-Carane 1 9 10 8 10 10 10 10 10 10 10 97  
43 1R,3Z,9S-
2,6,10,10-
Tetramethylbicycl
1 10 9 9 10 10 10 9 10 10 10 97  
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o[7.2.0]undeca-
2,6-diene 
44 (-)-Menthol  1 10 10 9 10 10 10 9 10 8 10 96  
45 2,4-Octadiene  
stereoisomers1 
1 10 10 10 10 10 10 10 8 9 10 97  
46 2,4-Octadiene  
stereoisomers2 
1 10 10 10 10 10 10 10 8 8 10 96  
47 Toluene 1 10 10 6 10 10 10 10 10 10 10 96 F 
48 2-Pentylfuran 1 10 10 10 8 10 7 10 10 10 10 95  
49 2-Pentanone 1 10 10 10 9 9 10 10 9 8 9 94  
50 2,3-Heptanedione 0 8 10 10 8 10 10 10 8 10 10 94  
51 β-Terpinene  0 10 10 9 10 10 10 8 10 7 10 94  
52 (-)-β-Bourbonene 1 10 9 9 10 10 10 10 10 6 10 94 F 
53 5-Methyl-2-
hexanone 
1 5 10 10 10 10 10 9 9 10 10 93  
54 2,5-Dimethyl-2,4-
hexadiene 
0 10 10 10 8 9 10 10 7 9 10 93  
55 Acetonitrile  1 10 10 10 9 6 10 9 10 10 9 93  
56 Methylene 
chloride 
1 10 10 10 9 6 10 9 10 10 9 93  
57 2-Butanone  1 10 9 10 7 9 10 10 10 10 7 92 A 
58 (S)-Carvone 1 10 6 10 10 10 10 9 8 9 10 92  
59 1-Dodecene 0 10 10 10 10 10 10 10 9 3 10 92  
60 Humulen-(v1) 1 10 10 10 10 10 10 10 8 4 10 92  
61 unknown_38  
(Retention time 
39.5mins) 
 10 10 9 10 10 10 10 9 4 10 92  
62 unknown_39  
(Retention time 
39.6mins) 
 10 10 9 10 10 10 10 9 4 10 92  
63 unknown_40  
(Retention time 
39.7mins) 
 10 10 9 10 10 10 10 9 4 10 92  
64 2-Decanone 0 5 10 10 9 10 10 8 9 10 10 91  
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65 Undecane 1 10 10 2 10 10 10 10 10 9 10 91  
66 β-Caryophyllene  1 10 10 8 10 10 10 10 8 5 10 91 B,F 
67 3-Methylbutanal 1 10 10 10 10 10 9 10 4 10 7 90  
68 Isothujol 0 10 8 9 10 10 10 10 10 4 8 89  
69 Camphene 1 10 9 0 10 10 10 10 10 10 10 89  
70 Benzene 1 10 10 10 2 10 10 10 9 8 10 89 F 
71 cis-3-Decene 1 10 10 10 10 10 9 10 3 6 10 88  
72 2-
Methylpropanoic 
acid 
1 10 10 10 6 10 10 10 6 8 8 88  
73 Anethole 1 10 10 9 10 9 10 9 10 1 10 88  
74 2-Propenoic acid, 
2-methyl-ethenyl 
ester 
0 10 10 10 5 9 10 10 6 8 9 87  
75 2-n-Butylfuran 0 10 10 10 7 10 10 10 9 1 10 87  
76  2-methyl-3-
Hexanone 
0 9 9 9 10 8 10 1 10 10 10 86  
77 Terpinolene 1 10 7 5 10 10 10 10 9 5 10 86  
78 Estragole  0 10 10 9 10 10 10 8 9 0 10 86  
79 Pentanal 1 10 10 10 2 9 6 10 8 10 10 85  
80 1-methyl-3-(2-
methyl-2-
propenyl)- 
Cyclopentane 
0 10 10 0 10 10 10 6 9 10 10 85  
81 Eucalyptol 1 9 7 3 10 9 10 10 9 10 8 85  
82 β-Cubebene 0 10 6 3 10 10 10 9 9 8 9 84  
83 5-Methyl-2-
heptanone 
1 1 10 10 9 10 9 6 10 8 10 83  
84 Ethyl acetate 1 10 9 7 8 10 10 10 3 9 7 83  
85 2-Methyl-
pentanal  
0 7 10 9 5 9 9 7 7 9 10 82  
86 1-Octen-3-one  1 3 9 10 7 7 10 10 8 8 10 82  
87 Calamenene 1 10 7 9 10 10 10 9 7 1 9 82  
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isomer 2 
88 1-Tetradecene  0 10 9 8 1 10 10 9 10 5 10 82 B 
89 γ- terpinene  1 10 5 0 10 7 10 10 9 10 10 81  
90 (E)-β-Bourbonene 0 10 7 5 10 10 9 9 5 6 10 81  
91 δ-Cadinene 1 10 7 4 10 7 10 10 8 7 8 81  
92 2,4-Dimethyl-2-
pentene 
0 10 10 10 0 10 10 10 4 8 8 80  
93 unknown_45 
(Retention time 
40.2 mins) 
 6 8 9 10 10 4 2 10 10 10 79  
94 Heptanal 1 9 10 10 1 10 3 9 9 7 10 78  
95 Octanal 1 10 9 10 1 10 1 7 10 10 10 78  
96 α-Terpinene 1 7 4 5 10 10 10 8 9 6 9 78  
97 β-Clovene 0 10 7 9 8 10 10 9 7 1 7 78  
98 4-Methylphenol 1 9 10 6 8 8 9 8 7 4 9 78 C, F 
99 2-Menthene 0 10 6 4 10 9 10 8 10 0 10 77  
100 (E)-5-Undecene,  0 10 9 2 0 10 9 10 10 7 10 77  
101 Isomenthone  1 1 10 3 10 10 10 9 9 6 8 76  
102 α-Muurolene 1 10 5 4 10 10 10 10 5 3 9 76  
103 (Z)-3-Octene 1 6 10 10 10 9 9 10 0 9 2 75  
104 β-Phellandrene  1 10 5 0 10 9 10 8 9 5 8 74  
105 (E)-7-Tetradecene 0 9 6 10 9 10 10 10 1 0 9 74  
106 2-Dodecanone 0 1 8 9 9 10 8 4 4 10 10 73 B 
107 isocaryophyllene 0 10 4 9 10 9 10 9 1 1 9 72  
108 p-Menthene 0 6 8 1 10 7 10 8 9 6 6 71  
109 Decanal 1 10 4 9 10 4 1 8 7 8 8 69 B 
110 unknown_28 
(Retention time 
32.82mins) 
 10 8 0 10 4 10 6 10 4 7 69  
111 unknown_34  
(Retention time 
35.5mins) 
 10 5 10 8 8 10 9 0 0 8 68  
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112 Cyclohexane 1 9 4 3 10 6 2 4 10 10 9 67  
113 unknown_48 
(Retention time 
42.55mins) 
 7 10 9 4 7 6 7 1 9 7 67  
114  6-Methyl-5-
hepten-2-one 
1 2 10 7 0 10 4 7 9 6 10 65  
115 Cyclotetradecane 0 10 6 9 4 9 9 8 0 0 10 65  
116 α-Bourbonene 0 10 3 6 10 9 8 9 1 1 7 64  
117 α-Calacorene 1 10 4 6 10 4 10 10 0 10 0 64  
118 3-Methyl-3-
phenyl-azetidine 
0 9 10 7 0 10 9 9 10 0 0 64  
119 Menthofurane 1 6 4 2 10 9 10 10 9 1 3 64  
120 Allo-ocimene 1 10 0 3 10 9 10 6 4 0 10 62  
121 n-Propyl acetate 1 0 7 10 9 9 3 7 3 5 9 62  
122 (Z)- 2-Octen-1-ol 0 8 7 7 5 7 2 2 7 8 8 61  
123 (+)-Ledene 1 10 1 7 10 7 9 8 9 0 0 61  
124 2-Ethyl-1-hexanol 1 10 4 10 0 6 6 7 1 6 10 60 F 
125 2-Nonadecanone 0 1 9 10 3 9 7 5 1 5 10 60  
126 α-Cubebene  0 10 2 7 8 6 9 9 1 4 4 60  
127  3-Methyl-
pentane 
0 9 5 6 9 4 1 3 9 6 7 59  
128 nerol  0 10 0 0 10 10 10 5 9 4 0 58  
129 Ylangene 0 9 1 0 7 5 8 8 4 7 8 57  
130 α-Phellandrene 1 10 0 0 10 10 10 6 6 4 0 56  
131 thymol 1 0 5 4 10 1 9 7 10 8 1 55  
132  2-methyl-2-
pentenal 
0 4 5 6 10 6 8 6 2 8 0 55  
133 unknown_18  
(Retention time 
26.83mins) 
 10 0 9 10 10 10 4 1 0 0 54  
134 2-Tridecanone 0 1 7 10 6 3 7 1 0 8 10 53 B 
135  2,7,7-trimethyl-
Bicyclo[2.2.1]hep
0 8 0 0 10 6 10 10 7 0 0 51  
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t-2-ene 
136 Allyl 
isothiocyanate 
1 0 9 6 0 2 9 10 5 6 4 51 F 
137 dimethyldisulfide  1 7 10 1 6 8 1 1 0 9 7 50 F 
138 β-Elemene 0 10 0 0 10 5 8 10 2 2 1 48  
139 Neoclovene 0 1 0 9 9 10 10 8 0 1 0 48  
140 1-Hexanol 1 2 9 10 0 4 0 0 2 9 10 46  
141 3-Methylene-
1,5,5-
trimethylcyclohex
ene 
0 1 0 0 9 5 10 7 8 5 0 45  
142 unknown_15 
(Retention  time 
25.11mins) 
 10 6 3 0 4 7 6 1 5 3 45  
143 unknown_43 
(Retention time 
39 mins) 
 9 2 5 7 2 10 8 0 2 0 45  
144 Heptane  1 4 6 7 0 8 9 6 1 0 2 43  
145 unknown_41  
(Retention time 
38.2 mins) 
 9 2 6 3 3 9 8 0 0 3 43  
146 1R,3Z,9s-4,11,11-
Trimethyl-8-
methylenebicyclo
[7.2.0]undec-3-
ene 
0 6 1 4 7 3 10 10 0 0 0 41  
147 unknown_23 
(Retention time 
30.86 mins) 
 0 0 9 8 4 5 3 6 4 2 41  
148 Copaene  1 9 1 8 5 4 5 7 0 0 0 39  
149 Methacrolein 1 0 8 4 0 5 7 3 0 9 2 38  
150 unknown_16  
(Retention time 
26.1 mins) 
 0 1 4 10 3 10 5 1 4 0 38  
151  3,5-dimethyl-
Cyclohexanol 
0 8 4 3 0 0 0 2 7 6 7 37  
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152  E-2-Octene 1 0 6 9 1 5 2 4 1 7 1 36  
153 R or S (-) 3,7-
Dimethyl-1,6-
octadiene  
0 0 0 9 3 6 2 5 8 3 0 36  
154 Hexylbenzene 0 4 8 3 0 4 5 3 3 0 6 36  
155 1-Dodecanol 0 10 5 0 0 3 0 7 0 0 10 35 C,F 
156 unknown_13 
(Retention time 
23.92 mins) 
 5 4 4 1 3 2 3 4 0 9 35  
157 2-Methylbutanal 1 0 3 9 3 8 0 0 1 9 1 34  
158 unknown_1   
(Retention time 
15.44 mins) 
 1 6 7 0 5 7 6 0 1 0 33  
159 3-octanone 1 0 10 0 0 0 0 4 1 6 10 31  
160 Methylcyclopenta
ne 
1 9 0 0 3 0 0 0 9 6 4 31 C 
161 unknown_22 
(Retention time 
30.72 mins) 
 8 0 0 10 1 6 5 0 1 0 31  
162 unknown_29  
(Retention time 
32.85 mins) 
 0 0 0 10 2 10 7 0 2 0 31  
163 3,4-
Dimethylcyclohe
xanol 
0 8 6 1 0 4 1 2 1 2 4 29  
164 Nonane 1 0 8 2 0 4 3 1 0 10 0 28  
165 1-methyl-3-(2-
methyl-1-
propenyl)- 
Cyclopentane 
0 2 0 1 8 0 10 2 0 5 0 28  
166 3-Methyl-1-
butanol 
1 0 8 0 0 2 0 9 0 0 8 27  
167 1-Pentanol 1 3 4 0 0 1 1 0 4 6 6 25  
168 (E)- 2-Butenal 1 0 6 3 0 6 9 0 0 1 0 25  
169 (+)-
Dihydrocarvone 
1 3 0 0 9 3 0 1 0 5 4 25  
 28 
170 Piperitone 1 2 1 2 3 2 4 6 0 0 5 25  
171 unknown_36 
(Retention time 
36.12 mins) 
 0 0 3 4 1 8 6 1 0 1 24  
172 unknown_12 
(Retention time 
20.71 mins) 
 1 0 3 1 4 6 0 4 4 0 23  
173 4,7-
Dimethylbenzofur
an 
1 0 0 0 10 0 2 2 8 1 0 23  
174 unknown_4  
(Retention time 
16.03 mins) 
 2 4 2 0 2 1 1 4 0 5 21  
175 unknown_30 
(Retention time 
40.83 mins) 
 4 8 3 0 0 3 1 0 0 2 21  
176  (2α,3β,5β)-1,1,2-
trimethyl-3,5-
bis(1-
methylethenyl)-
Cyclohexane 
0 1 4 6 0 4 1 3 1 0 0 20  
177 4,5,9,10-dehydro-
Isolongifolene 
1 6 0 1 4 0 4 4 0 0 1 20  
178 (E,E)-2,4-
Nonadienal  
isomer??  
0 0 0 0 8 0 8 3 0 0 0 19  
179  3-Methylheptane 0 7 0 0 7 0 0 0 3 1 1 19  
180 Dodecane 1 0 0 0 0 0 0 2 7 10 0 19 B 
181 Δ-Cadinene 0 1 0 3 7 1 0 5 2 0 0 19  
182 (Z)- 2-Heptenal 1 0 0 0 0 0 0 0 0 8 10 18  
183 4-Heptanone 0 0 0 6 0 0 0 0 0 6 6 18  
184 (E)-4,4-Dimethyl-
2-pentene 
0 0 0 0 0 0 0 0 9 0 9 18  
185 (E)- 1-
(methylthio)-1-
propene, 
1 0 3 1 0 1 5 2 0 5 1 18  
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186  3-Methyl-3-
buten-2-one 
0 0 5 3 0 1 5 1 1 1 0 17  
187 trans-
Dihydrocarvone  
1 0 0 0 8 3 0 0 0 2 4 17  
188 unknown_42 
(Retention time 
38.7 mins) 
 6 1 4 0 0 1 5 0 0 0 17  
189 Allyl 
methylsulfide 
0 0 1 0 0 5 5 2 0 4 0 17  
190 unknown_2    
(Retention time 
15.53 mins) 
 1 2 2 1 3 3 1 0 1 2 16  
191 (dimethylamino)-
Acetonitrile 
0 0 0 0 0 0 0 0 8 1 7 16  
192  3-Methyl-1-
penten-3-ol 
0 7 0 2 0 0 0 0 1 4 1 15  
193 Isoterpinolene 0 6 0 0 5 0 1 3 0 0 0 15  
194 unknown_3  
(Retention time 
15.69 mins) 
 3 4 0 1 2 1 3 0 0 1 15  
195  (E)- or (Z) 2-
Nonenal 
1 0 0 0 0 0 0 0 6 8 0 14 C 
196 (E)- 3-Octene 0 0 0 3 6 0 0 0 0 5 0 14  
197 Tricyclene 1 1 0 0 9 3 1 0 0 0 0 14  
198 Isolimonene 1 0 0 0 10 0 1 0 0 3 0 14  
199  (E,Z)-2,4-
Dodecadiene 
0 5 3 0 0 1 0 1 0 0 4 14  
200 unknown_11  
(Retention time 
19.93 mins) 
 2 4 1 0 1 2 2 0 2 0 14  
201 (Z)-1-
(methylthio)-1-
propene,  
1 0 1 0 0 0 5 2 1 5 0 14  
202 1-(3-
methylbutyl)-
Cyclopentene 
0 0 1 0 0 0 8 3 0 1 0 13  
203 2-Propenal 1 0 5 0 1 0 5 0 0 1 0 12  
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204 Propanal 1 0 0 0 10 0 0 0 0 1 1 12  
205 1-Penten-3-one 1 0 5 0 1 0 2 1 0 1 2 12  
206 (-)-β-Pinene 0 2 0 0 10 0 0 0 0 0 0 12  
207 α-Fenchene 0 0 0 0 10 0 0 0 0 2 0 12  
208 β-Myrcene 1 0 2 0 0 0 0 0 0 10 0 12  
209 2-Octanone 0 0 1 0 0 0 4 0 0 0 6 11  
210 2-Methylpentane 0 0 1 0 4 0 0 0 2 0 4 11  
211 unknown_17 
(Retention time 
26.25 mins) 
 0 0 0 9 0 0 0 0 2 0 11  
212  E,E-2,6-
Dimethyl-1,3,5,7-
octatetraene 
0 3 0 0 5 2 0 0 0 0 0 10  
213 1,3,8-p-
Menthatriene 
1 1 1 0 5 0 0 0 0 1 2 10  
214 (E)-or (Z) 6-
Tridecene 
0 0 0 0 0 0 0 2 0 0 8 10  
215 unknown_10  
(Retention time 
17.83 mins) 
 2 3 4 0 0 0 0 0 0 1 10  
216 unknown_31 
(Retention time 
33.85 mins) 
 0 0 8 0 1 0 1 0 0 0 10  
217 unknown_32  
(Retention time 
34 mins) 
 0 0 8 0 1 1 0 0 0 0 10  
218 Isopropyl 
myristate 
1 3 0 0 0 0 0 3 0 0 4 10 F 
219 (R)-2-Butanol,  0 0 0 0 0 0 0 0 0 8 0 8 E 
220 (E) 2-Methyl-2-
butenal,  
1 0 0 0 1 0 0 0 0 7 0 8  
221 (2-
methylenebutyl)-
Cyclopropane 
0 0 0 4 3 0 1 0 0 0 0 8  
222 3,3,5-Trimethyl-
heptane 
0 0 1 2 1 1 1 2 0 0 0 8  
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223 unknown_44 
(Retention time 
40.12 mins) 
 0 0 0 0 0 2 6 0 0 0 8  
224 Dodecanoic acid 
ethyl ester 
0 0 0 0 8 0 0 0 0 0 0 8  
225 2,3-Octanedione 1 7 0 0 0 0 0 0 0 0 0 7  
226 trans-β-Ocimene 1 0 0 0 0 0 0 6 0 1 0 7  
227 1,2-dimethyl-3,5-
bis(1-
methylethenyl)-
Cyclohexane 
0 0 0 6 0 0 0 1 0 0 0 7  
228 (-)-β-Cadinene 0 0 0 0 7 0 0 0 0 0 0 7  
229 unknown_21 
(Retention time 
29.71 mins) 
 0 2 0 0 1 1 2 0 0 1 7  
230 unknown_47 
(Retention time 
41.42 mins) 
 2 1 1 0 1 0 2 0 0 0 7  
231 1-(Methylthio)-
propane 
1 0 2 0 0 0 1 2 0 2 0 7  
232 (-)-Calamenene 
isomer 3  
1 0 1 2 0 1 1 1 0 0 0 6  
233 unknown_14  
(Retention  time 
23.98 mins) 
 0 0 0 2 0 0 0 3 1 0 6  
234 unknown_24  
Isomer 1  
(Retention time 
40.83mins) 
 0 0 5 1 0 0 0 0 0 0 6  
235 Isomenthyl 
acetate 
0 0 6 0 0 0 0 0 0 0 0 6  
236 2-Acetyl-5-
methylfuran 
0 0 0 0 0 0 0 0 4 2 0 6  
237 Dihydrocarveol 0 0 0 0 1 0 0 1 0 1 2 5  
238 2-Ethyl-2-hexenal 1 0 0 5 0 0 0 0 0 0 0 5  
239 Methyl vinyl 
ketone 
1 0 3 0 0 0 2 0 0 0 0 5  
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240 3-
Methyleneheptan
e 
0 0 0 5 0 0 0 0 0 0 0 5  
241 3-Methyl-3-
heptene 
0 0 0 4 0 0 0 0 0 1 0 5  
242 1-Acetyl-2-
methylcyclopente
ne 
0 0 0 5 0 0 0 0 0 0 0 5  
243 2,4-Dimethyl-1-
(1-methylethyl)-
benzene 
0 0 0 0 0 0 0 0 0 5 0 5  
244 1-(1-
methylethenyl)-3-
(1-methylethyl)-
Benzene 
0 0 0 5 0 0 0 0 0 0 0 5  
245 unknown_25 
(Retention time 
31.03mins) 
 0 0 0 0 0 0 0 1 0 4 5  
246 n-Propyl 
isobutyrate 
0 0 0 1 4 0 0 0 0 0 0 5  
247 1-Methoxy-4-
propyl-benzene 
0 0 0 0 1 0 1 3 0 0 0 5  
248 (E)-2-Hexenal 1 0 0 0 0 0 0 0 1 3 0 4  
249 2,3-Hexanedione 0 0 1 2 0 1 0 0 0 0 0 4  
250 (E)-2-Heptene 0 0 0 3 0 0 1 0 0 0 0 4  
251 3-Heptene 0 0 0 4 0 0 0 0 0 0 0 4  
252  3-Methyl-1-
heptene 
0 0 0 4 0 0 0 0 0 0 0 4  
253 4-Methyl-3-
heptene 
0 0 0 4 0 0 0 0 0 0 0 4  
254 (E)- 4-methyl-2-
heptene  
0 0 0 4 0 0 0 0 0 0 0 4  
255 (E)-4-Octene 0 0 0 4 0 0 0 0 0 0 0 4  
256 (Z)- 4-Octene 0 0 0 4 0 0 0 0 0 0 0 4  
257 (3-methyl-2-
butenyl)-benzene 
0 0 0 4 0 0 0 0 0 0 0 4  
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258 Methyl 
propionate 
0 0 1 0 0 1 0 0 0 2 0 4  
259 Dioctyl ether 0 0 0 0 0 0 1 0 0 0 3 4 B 
260 Perilla aldehyde 0 0 0 0 0 0 0 0 0 0 3 3  
261 (Z)-3-Heptene 0 0 0 3 0 0 0 0 0 0 0 3  
262 Santolina triene 0 0 0 0 3 0 0 0 0 0 0 3  
263 (R)-(+)-p-Menth-
3-ene 
0 0 1 0 0 0 1 0 0 1 0 3  
264 1-methyl-4-(1-
methyl-2-
propenyl)-
Benzene 
0 0 0 0 0 0 0 0 0 3 0 3  
265 γ-Muurolene 0 0 0 3 0 0 0 0 0 0 0 3  
266 unknown_7  
(Retention time 
17.06mins) 
 0 0 0 0 0 0 0 2 1 0 3  
267 unknown_24 
Isomer 2  
(Retention  time 
31.12 mins) 
 0 0 2 1 0 0 0 0 0 0 3  
268 unknown_46 
(Retention time 
40.83mins) 
 0 1 1 0 1 0 0 0 0 0 3  
269 Isothiocyanatocyc
lopropane  
0 0 0 0 0 0 0 0 0 3 0 3  
270 n-Propyl butyrate 0 0 0 0 3 0 0 0 0 0 0 3  
271 Acetic acid 2-
ethylhexyl ester  
0 0 0 3 0 0 0 0 0 0 0 3  
272 Heptylbenzene 0 0 0 0 0 0 0 0 0 0 3 3  
273 2-Propen-1-ol 0 0 0 0 0 0 0 0 0 2 0 2  
274 γ-Nonalactone    1 0 0 0 1 0 0 0 0 1 0 2 B 
275 3-Penten-2-one 1 0 0 0 0 0 0 0 0 0 2 2  
276 Megastigmatrieno
ne 
0 0 0 0 0 1 0 1 0 0 0 2  
277 1,1'- 0 0 0 2 0 0 0 0 0 0 0 2  
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ethylidenebis-
Cyclopentane 
278 1-methyl-4-(1-
methylpropyl)-
Benzene 
0 0 0 2 0 0 0 0 0 0 0 2  
279 (3-methyl-2-
butenyl)-Benzene 
1 0 0 2 0 0 0 0 0 0 0 2  
280 Tetradecane 0 0 0 1 0 0 0 1 0 0 0 2 C, B 
281 unknown_5    
(Retention time 
16.18mins) 
 0 0 0 1 0 0 0 0 1 0 2  
282 unknown_8  
(Retention time 
17.13mins) 
 0 0 0 0 0 0 0 2 0 0 2  
283 unknown_19 
(Retention time 
27.47mins) 
 0 0 0 0 0 0 2 0 0 0 2  
284 Acetic acid 1-
methylethyl ester  
0 0 0 0 0 1 0 0 0 1 0 2  
285 Furan, 2,4-
dimethyl- 
0 0 0 0 0 0 0 0 0 2 0 2  
286 (Z)- 2-Butenal,  0 0 0 0 0 0 0 0 0 1 0 1  
287 α-Methyl-
cinnamaldehyde 
1 0 0 0 0 0 0 0 0 1 0 1  
288 3-Phenyl- 2-
propenal 
1 0 0 0 0 0 0 0 0 1 0 1  
289 γ-Heptalactone    1 0 0 0 0 0 0 0 0 1 0 1 B 
290 γ-Undecalactone 0 0 0 0 0 0 0 0 1 0 0 1  
291 1,3-Dihydro-2H-
indol-2-one 
0 0 0 0 0 1 0 0 0 0 0 1  
292 Pulegone 1 0 0 0 0 0 1 0 0 0 0 1  
293 Propane 1 0 0 0 0 1 0 0 0 0 0 1  
294 2-Methyl-heptane 1 0 0 0 0 0 0 0 1 0 0 1  
295 3-(2-
Methylpropyl)-
cyclohexene 
0 0 0 0 0 0 1 0 0 0 0 1  
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296 β-Z-Ocimene 0 0 0 1 0 0 0 0 0 0 0 1  
297 4-Methyl-2-
methylene-1-(1-
methylethylidene)
-cyclohexane 
0 0 0 0 0 0 0 0 0 1 0 1  
298 1,3-bis(1-
methylethyl)-1,3-
Cyclopentadiene 
0 0 0 0 0 0 0 0 0 1 0 1  
299 (E)-2-Dodecene 0 0 0 1 0 0 0 0 0 0 0 1  
300 (E,Z)-2,4-
Dodecadiene 
0 1 0 0 0 0 0 0 0 0 0 1  
301 1-(1-
Methylethenyl)-4-
(1-methylethyl)-
benzene 
0 0 0 1 0 0 0 0 0 0 0 1  
302 1,8-Nonadiene, 
2,7-dimethyl-5-
(1-
methylethenyl)- 
0 0 0 1 0 0 0 0 0 0 0 1  
303 Cadalene 0 0 1 0 0 0 0 0 0 0 0 1  
304 1-Methyl-2-n-
hexylbenzene 
0 0 0 0 0 0 0 0 0 0 1 1  
305 Ar-curcumene 0 0 0 0 0 0 0 0 0 1 0 1  
306 unknown_6  
(Retention time 
16.23mins) 
 0 0 0 0 0 0 0 0 1 0 1  
307 unknown_9  
(Retention time 
17.33mins) 
 0 0 0 0 0 0 0 0 1 0 1  
308 unknown_20 
(Retention time 
29.57mins) 
 0 0 1 0 0 0 0 0 0 0 1  
309 unknown_26 
(Retention time 
31.47mins) 
 0 0 0 0 0 0 0 0 1 0 1  
310 unknown_27 
(Retention time 
 0 0 0 0 0 1 0 0 0 0 1  
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32.05mins) 
311 unknown_33  
(Retention time 
35.32mins) 
 0 0 1 0 0 0 0 0 0 0 1  
312 unknown_35  
(Retention time 
35.7 mins) 
 0 0 1 0 0 0 0 0 0 0 1  
313 Allyl mercaptan 1 0 0 0 0 0 0 0 0 1 0 1  
314 Thiazole 1 0 0 0 0 0 0 0 0 1 0 1  
315 Menthyl acetate 1 0 0 0 1 0 0 0 0 0 0 1  
316 3-Methyl-
pyridine 
0 0 0 0 0 0 0 0 0 1 0 1  
317 2-Methyl-
pyridine 
0 0 0 0 0 0 0 0 0 1 0 1  
 
A: Kumar et al 2009, B: Soini et al 2010, C: Alagendran et al 2010, D: Penn et al 2007, E: Lochner et al 1986, F: Kostelc et al 1981, G: Larsson 1965.  
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Table (3): Numbers of volatile organic compounds in saliva across subjects and between samples in the longitudinal study 
 Number of compounds identified     
 day 1 day 2 day 3 day 4 day 5 day 6 day 7 day 8 day 9 day 10 AVG STDEV Total 
compounds in 
all 10 samples 
compounds 
in every 
sample 
Subject_1  139 138 134 143 146 144 138 139 140 142 140 3 179 102 
Subject_2 118 122 124 128 133 144 133 147 146 131 133 10 187 85 
Subject_3 127 131 142 151 138 103 160 139 141 137 137 15 206 74 
Subject_4 143 158 152 155 151 128 152 147 132 149 147 10 189 104 
Subject_5 119 138 132 144 150 135 149 142 145 144 140 9 194 94 
Subject_6 153 159 145 151 148 146 132 160 155 150 150 8 199 109 
Subject_7 123 130 146 141 121 154 160 159 155 140 143 14 202 81 
Subject_8 95 124 114 124 129 119 118 124 122 137 121 11 171 65 
Subject_9 115 127 128 142 122 138 119 122 121 128 126 8 211 66 
Subject_10 143 141 129 132 136 147 138 140 134 138 138 5 180 94 
           137 (AVG),  
3.6 (STDEV) 
 192 (AVG),  
13(STDEV) 
87 (AVG),  
16(STDEV) 
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Table (4): The inter subject and overall variability in the levels of the 34 ubiquitous compounds. The overall variability is calculated from a ratio of the maximum and minimum peak 
area values for a given compound for all 10 subjects over the 10 day period. Individual variability is calculated from a ratio of the maximum and minimum peak area values for a 
given compound for a single subject over the 10 day period. 
Compound Name 
Subject 
1 
Subject 
2 
Subject 
3 
Subject 
4 
Subject 
5 
Subject 
6 
Subject 
7 
Subject 
8 
Subject 
9 
Subject 
10 
over all 
variability 
2,3-Butanedione 4 4 2 9 4 3 7 5 4 5 41 
E or Z-1,3-octadiene Stereoisomers1   4 5 2 8 3 5 2 3 5 6 13 
E or Z-1,3-octadiene Stereoisomers2 4 4 3 4 3 5 3 4 5 12 14 
2,3-Pentanedione  7 15 5 12 5 7 9 5 8 9 48 
Hexane  6 6 5 17 7 7 8 17 6 7 55 
2-methyl-1-Propanol   5 3 2 7 5 3 2 3 3 3 11 
Indole     6 3 6 26 4 4 7 3 7 17 29 
Octane   126 101 18 337 89 61 20 588 18 169 860 
Styrene    1 102 2 4 6 2 4 4 2 3 102 
o-Xylene  1 102 2 4 6 2 4 4 2 3 102 
unknown_37   6 3 6 26 4 4 7 4 7 17 41 
 2-butyl-1-Octanol          3 21 14 6 6 4 8 2 2 7 48 
Dodecanal    6 3 6 26 4 4 7 6 7 17 70 
Nonanal   16 5 3 10 5 9 6 10 5 4 56 
Calamenene isomer 1          3 21 14 6 6 4 8 2 2 7 48 
2-Heptanone   3 16 3 4 3 6 4 4 4 6 27 
Ethanol    4 3 4 12 17 54 4 13 10 7 57 
Acetone    4 4 3 3 27 9 12 12 4 6 73 
Isopropyl Alcohol   3 3 8 5 108 12 11 65 36 8 253 
1S,2S,5R-1,4,4-Trimethyltricyclo[6.3.1.0(2,5)]dodec-
8(9)-ene   3 62 18 7 5 4 8 4 5 7 131 
Hexanal  13 5 2 8 6 5 3 2 3 21 141 
 2,4-dimethyl-3-Pentanone    3 5 9 4 5 5 6 2 6 2 40 
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2-Octene Z or E  5 8 36 7 3 3 2 8 4 6 124 
1-Butanol     1 2 3 5 3 2 4 2 3 2 10 
Phenol   5 8 8 33 16 8 12 6 11 7 170 
Pyrrole    13 5 2 8 6 5 3 2 3 21 106 
p-Xylene     5 8 4 6 6 4 3 2 3 7 25 
trans-Carane     7 13 8 17 12 20 48 9 62 13 736 
Dehydro-p-cymene   11 7 9 6 17 6 12 36 128 7 759 
1R-α-Pinene  9 21 10 7 20 9 21 11 8 6 377 
1-Propanol  10 3 3 14 14 32 10 4 5 11 3751 
3-(2-propenyl)-Cyclohexene     3 8 15 4 7 3 4 3 4 7 65 
P-cymene    13 6 16 6 22 6 17 35 91 5 605 
Limonene    12 11 37 3 33 7 27 19 101 65 1203 
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FIG 1_a: 2-methyl-1-propanol 
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FIG 1_b: Styrene  
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FIG 1_c: Isopropyl alcohol    
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FIG 1_d:   Acetone 
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FIG 1_e:   Ethanol 
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FIG 1_f:   Limonene 
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FIG 1_g:   1-Propanol   
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FIG 1_h:   Octane 
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Figure (1): Showing the daya to day variation in 10 ubiquitous compounds (a: Styrene, b: Isopropyl alcohol, c: Acetone, d: Limonene, e: 1-Propanol, f: Phenol, g:  Ethanol, h: 
Octane, i: Z -2-Octene, j: Hexanal) present in the saliva of 10 healthy individuals.  
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